ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1188

High Risk of Stroke in Men with Joint Prosthesis Due to Osteoarthritis: The Prospective STRAMBO Study

MAXIME AUROUX1, PAWEL SZULC2 and ROLAND CHAPURLAT1, 1Hospices Civls de Lyon, LYON, Rhone-Alpes, France, 2INSERM U1033, LYON, Rhone-Alpes, France

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Osteoarthritis, Stroke

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) and cardiovascular disease share risk factors. The impact of OA on cardiovascular and especially cerebrovascular outcomes is still debated. Our aim was to assess the association between OA and the risk cardiovascular or cerebrovascular events in a cohort of older men followed prospectively for 8 years.

Methods: The STRAMBO study has involved men aged 60 to 87 years at baseline. We examined the relationship between joint replacement due to OA before baseline and incident cardiovascular events. Major adverse cardio- and cerebrovascular event (MACCE) – were defined as an acute coronary syndrome (ACS), stroke or sudden death probably of cardiovascular origin. ACS comprised myocardial infarction, cardiac arrest and unstable angina necessitating emergency intervention. The association between OA and the risk of outcomes was assessed using a Cox model adjusted for age, BMI, occupational physical activity, smoking, ischaemic heart disease, hypertension, abdominal aortic calcification, treatment with statins, treatment with vitamin K antagonists. Other potential relevant confounders such as diabetes mellitus or low leisure physical activity were not included in the model because they were not significant predictors.

Results: The mean age and BMI of 816 men were 72 years and 27.6 kg/m2. Among them, 49 men reported joint replacement due to OA at baseline (18 knees, 30 hips, 6 shoulders, 6 men had two joint replacements). Men who had joint replacement were older (76.6 vs 71.8 years, p< 0.001) and heavier (29.6 vs. 27.5 kg/m2, p< 0.001). They more often self-reported high occupational physical activity, ischaemic heart disease, diabetes mellitus, and the treatment with beta blockers (significant after adjustment for age).

During the follow-up, 90 men had incident MACCE, with a median [interquartile range] follow-up time to event of 51.6 months [27.5; 71.0]. Men who sustained incident MACCE were at baseline older (75.2 vs. 71.8 years, p< 0.01). They more often self-reported high occupational physical activity, ischaemic heart disease, diabetes mellitus (significant after adjustment for age). The risk of MACCE in men with joint replacement was higher compared with the controls (HR = 3.12, 95%CI 1.74 – 5.58, p< 0.001). Men with OA had increased HR for stroke (n = 38) of 4.94 (95%CI: 1.96; 12.42, p< 0.001) with a median follow-up time to event of 51.0 month [23.3; 72.9].

We did not observe such an association for ACS (n = 50, HR = 1.30, 95%CI: 0.49; 3.40, p=0.60) or for myocardial infarction (n = 29, HR = 1.35, 95%CI: 0.39; 4.68, p=0.64).

Finally, 116 men reported major elective surgery due to other reason than OA during the follow-up. Their risk of MACCE was not increased compared to patients who did not report major surgery (HR=1.03, 95%CI: 0.42-2.55, p=0.95), suggesting that the association we observe is not mediated by surgical risks.

Conclusion: Late-stage OA, defined by joint replacement, was associated with a higher risk of stroke in a prospectively followed cohort of men, after adjustment for relevant confounders. As our results suggest an association between severe OA and the risk of stroke, cerebrovascular risk assessment could be considered in the management of patients with severe OA.

Supporting image 1

Supporting image 2


Disclosures: M. AUROUX: None; P. SZULC: None; R. CHAPURLAT: None.

To cite this abstract in AMA style:

AUROUX M, SZULC P, CHAPURLAT R. High Risk of Stroke in Men with Joint Prosthesis Due to Osteoarthritis: The Prospective STRAMBO Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/high-risk-of-stroke-in-men-with-joint-prosthesis-due-to-osteoarthritis-the-prospective-strambo-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-risk-of-stroke-in-men-with-joint-prosthesis-due-to-osteoarthritis-the-prospective-strambo-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology